The
first and only FDA-approved eye drop specifically designed for presbyopia in adults.1,2 A daily first-line treatment for mild-to-moderate patients with presbyopia.1,3

Reengineered Formulation

Designed to balance

efficacy, safety, and tolerability1,2

VUITY (pilocarpine HCI ophthalmic solution) 1.25%

Delivered with pHastTM technology Rapidly adjusts to physiologic pH*2

*In vitro data. Clinical significance is unknown. The pH range in the bottle is between 3.5 and 5.5.1

See how VUITY™ works

Improved near and intermediate vision without compromising
distance vision1

Primary endpoint was the proportion of patients gaining ≥3 lines in mesopic, high-contrast, binocular distance-corrected near visual acuity (DCNVA) without losing more than 1 line (5 letters) of corrected distance visual acuity (CDVA) with the same refractive correction at Day 30, Hour 3.1

Change from baseline in photopic, high-contrast, binocular distance-corrected intermediate visual acuity (DCIVA) at Day 30, Hour 3 was a prespecified secondary endpoint.4

One drop going into a puddle

VUITYTM has a well-established safety and tolerability profile1

NEARLY 9/10

Trial participants [N=76] surveyed would ask their eye doctor for VUITYTM†5

Assessed by a survey in a subset of participants in the VUITY™ arm of GEMINI 1 and GEMINI 2 studies.

Not an actual patient

How to get your patients with presbyopia started

VUITY™ speaker event

Hear from a renowned expert on how VUITY™ may benefit your patients.